STAT+: European Commission investigates Vifor for ‘disparaging’ its only rival in iron deficiency market
The European Commission has opened an investigation into allegations that Vifor Pharma spread misleading information…
Category: Pharma
STAT+: Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs
Good morning, everyone, and welcome to another working week, although today is actually a holiday…
STAT+: Pharmalittle: FTC warns pharma and PBMs about rebate schemes; WTO reaches Covid vaccine patent waiver deal
And so, another working week will soon draw to a close. Not a moment too…
STAT+: WTO reaches a deal on Covid vaccine patent waivers, but industry and advocates remain unhappy
After nearly two years of talks, the World Trade Organization reached an agreement to temporarily…
STAT+: FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes
In a notable move, the Federal Trade Commission put drugmakers and pharmacy benefit managers on…
STAT+: Pharmalittle: CVS whistleblower suit details plans to boost consumer drug costs; Roche reports negative Alzheimer’s trial results
Hello, everyone, and how are you today? Another dank cloudy cover greeted us this morning,…
STAT+: A Roche treatment fails to slow cognitive decline in patients with inherited form of Alzheimer’s disease
Roche reported negative results Thursday from a long-running clinical trial investigating an experimental antibody treatment…
STAT+: A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices
The conversation reflected frustration and disbelief. A woman had called SilverScript, which runs one of…
Popular drug may have new benefit in men with diabetes, but not women, study shows
A new study finds that a popular erectile dysfunction drug, which is increasingly being used…
STAT+: Pharmalittle: FDA panel to review Covid shots for young children; Shionogi to license antibiotic to dozens of poor countries
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: FDA oversight of pharma manufacturing facilities plunges during the pandemic
Each year, the Food and Drug Administration tracks its progress inspecting pharmaceutical manufacturing facilities and…
STAT+: In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries
In a first-of-its-kind arrangement, Shionogi has reached an agreement with the Global Antibiotic Research and…
STAT+: Pharmalittle: Lawmakers urge FTC to probe blood thinner prices; EU pressures Covid vaccine makers to renegotiate contracts
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: A widely anticipated ALS drug wouldn’t be cost effective if priced the same as an older rival
Amid growing demand for ALS treatments, a preliminary analysis finds an experimental medicine that may…
STAT+: FDA approved more cancer drugs than EMA, but they may not have always benefited patients
Amid rising pressure to endorse new medicines, U.S. regulators greatly outpaced their European counterpart in…
STAT+: Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Simmering disputes persist as Covid patent waiver talks come down to the wire
On Sunday, the World Trade Organization will hold a long-delayed ministerial conference to craft a…
Opinion: Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity
When the history of the Covid-19 pandemic is written, readers will be as stunned by…
STAT+: Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: FDA decision on Novavax Covid shot could be delayed; new drug prices rose 20% annually in recent years
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: How high? Prices for newly launched medicines rose 20% annually, analysis finds
Talk about inflation Amid ongoing angst over prescription drug costs, a new analysis finds that…
STAT+: Pharmalittle: FDA panel endorses Novavax Covid shot; FTC to probe pharmacy benefit managers
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: FTC will investigate pharmacy benefit managers and their role in prescription drug costs
After months of deliberation, the U.S. Federal Trade Commission has voted unanimously to investigate several…
STAT+: Pharmalittle: FDA panel will scrutinize Novavax shot for Covid-19; J&J and Emergent accuse each other of breach
Top of the morning to you, and a fine one it is. Blue skies and…
STAT+: Former Lilly manager files whistleblower lawsuit over manufacturing failures at production plant
A former Eli Lilly human resources officer sued the drug company after claiming she lost…
Opinion: It’s time to move past Aduhelm and focus on a broader Alzheimer’s drug pipeline
When Alzheimer’s disease was believed to be caused solely by the accumulation of amyloid protein…
STAT+: ‘All about strengthening health systems’: New coalition pushes to license cancer drugs to low-income countries
Over the past two decades, public health officials and patient advocacy groups have pushed the…
STAT+: Pharmalittle: Cancer drug trial yields remission in every patient; Novartis data hacked by extortionists
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Roche’s Tigit troubles escalate, sparking more debate about the closely tracked cancer immunotherapy target
CHICAGO — Roche had previously announced the failure of its closely tracked anti-TIGIT immunotherapy in…
STAT+: Pharmalittle: Bristol Myers will pay $4.1 billion for Turning Point; Europe looks to approve a smallpox vaccine for monkeypox
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: ‘Gloomy’ report issued on WTO Covid-vaccine proposal; biotech ‘swoon’ hits enterprise value at many companies
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Italian authorities fine drugmaker for ‘excessive’ pricing of a rare disease drug
Antitrust regulators in Italy have fined a drugmaker nearly $3.8 million for years of “excessive”…
STAT+: Pharmalittle: Pfizer to exit consumer-health joint venture with GSK; access to obesity drugs in U.S. remains ‘dismal’
Top of the morning to you, and a fine one it is, despite the cloudy…
STAT+: Former AstraZeneca executive charged with insider trading over Daiichi cancer drug deal
A former AstraZeneca communications executive was accused of insider trading in connection with a partnership…
STAT+: Documents show problems at Novartis facility where cancer drug production was halted
Earlier this month, Novartis took the surprising step of voluntarily suspending production of two therapies…
STAT+: Pharmalittle: GSK to pay up to $3.3 billion for Affinivax; Senate bill tries to avoid another Aduhelm controversy
Good morning, everyone, and welcome to another working week. We hope the weekend respite, which…
STAT+: While a law designed to thwart counterfeit medicines lurches into full force, fake pills keep circulating
As far as Shane Jerominski was concerned, the many bottles of a widely used HIV…
STAT+: The World Health Assembly moves to bolster clinical trials, but some say it falls short
In response to the Covid-19 pandemic, the World Health Assembly adopted a resolution designed to…
STAT+: ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when
In response to criticism, ViiV Healthcare has agreed to license its long-acting injectable HIV prevention…
STAT+: Pharmalittle: Will widening access to a Covid pill cause resistance? Monkeypox vaccine maker doesn’t see ‘panic’
And so, another working week will soon draw to a close. This is, as you…
STAT+: As monkeypox spreads, Bavarian Nordic’s CEO is fielding calls for his vaccine, but doesn’t see panic
As monkeypox threatens to become the latest global health concern, Bavarian Nordic has suddenly become…
STAT+: Pharmalittle: Teva and Allergan reach $161 million opioid settlement with West Virginia; FDA lifts hold on Bharat Covid shot
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
Opinion: STAT+: QR codes can help pharmaceutical companies in two big ways
QR codes, which had begun a fall into obscurity, have come roaring back. Many restaurants…
STAT+: Pharmalittle: Pfizer to sell medicines and vaccines to poor countries at low prices; Germany orders vaccine to combat monkeypox
Hello, everyone, and how are you this fine, sunny morning? Birds are chirping and cool…
STAT+: Pfizer will sell its patent-protected medicines and vaccines to poor countries at low prices
In an ambitious move to widen access to its medical products, Pfizer said Wednesday that…
STAT+: Pharmalittle: Is the Covid-19 gold rush over for drugmakers? Monkeypox attracts interest from vaccine makers
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Pfizer and BioNTech seek Covid-vaccine use in kids under 5; Pfizer refunds $290,000 over misleading coupons
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pfizer to refund $290,000 to consumers in four states over misleading copay couponds
Amid controversy over the use of patient coupons, Pfizer has agreed to refund $290,000 to…
STAT+: European regulator suspends generic drugs after finding flawed studies
In the latest dust-up over the safety of medicines, the European Medicines Agency recommended suspending…
.jpg)
STAT+: Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
And so, another working week will soon draw to a close. This is, as you…